IP Verse

Fusion Proteins Comprising A Binding Protein And An Interleukin-15 Polypeptide Having A Reduced Affinity For Il15Ra And Therapeutic Uses Thereof

Patent No. EP3265478 (titled "Fusion Proteins Comprising A Binding Protein And An Interleukin-15 Polypeptide Having A Reduced Affinity For Il15Ra And Therapeutic Uses Thereof") was filed by Dkfz Deutsches Krebsforschungszentrum on Mar 7, 2016. The application was issued on Sep 11, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONJun 11, 2020MEWBURN ELLIS
PFIZERJun 10, 2020PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3265478

DKFZ DEUTSCHES KREBSFORSCHUNGSZENTRUM
Application Number
EP16708154A
Filing Date
Mar 7, 2016
Status
Revoked
Dec 22, 2023
Publication Date
Sep 11, 2019
External Links
Slate, Register , Google Patents